SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer

Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Cytokine & growth factor reviews (Impact Factor: 6.54). 05/2012; 23(3):127-38. DOI: 10.1016/j.cytogfr.2012.04.005
Source: PubMed

ABSTRACT Inflammatory bowel disease (IBD) has unclear pathogenesis and it is related to the increasing risk of developing colorectal cancer (CRC). Recent studies have uncovered the molecular mechanism of intracellular signaling pathways of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-6. The major transcription factors including STAT3 have been shown to play a major role in transmitting inflammatory cytokine signals to the nucleus. The suppressors of cytokine signaling (SOCS) 3 protein is the key physiological regulators of cytokine-mediated STAT3 signaling. As such it influences the development of inflammatory and malignant disorders like this associated with IBD. Here we review the complex function of SOCS3 in innate and adaptive immunity, different cell types (macrophages, neutrophils, dendritic cells, B cells, T cells and intestinal epithelial cells) and the role of SOCS3 on the pathogenesis of inflammatory bowel disease (IBD) and IBD-related cancer. Finally, we explore how this knowledge may open novel avenues for the rational treatment of IBD and IBD-related cancer.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Our understanding of how axon regeneration is controlled in both the peripheral and central nervous systems remains fragmentary. Research into the regenerative capacity of adult neurons has elucidated PTEN and SOCS3 as distinctive but complementary arms of the regenerative program. These molecules act as negative regulators of major signaling pathways and impact the processes occurring in the cell body, such as protein translation and transcription, and in the axons, such as cytoskeleton assembly. In this review, we summarize the role of PTEN and SOCS3 in limiting axon regeneration and discuss the molecular and cellular mechanisms underlying their growth-inhibitory effects.
    International Review of Neurobiology 01/2012; 105:141-73. DOI:10.1016/B978-0-12-398309-1.00008-1 · 2.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ulcerative colitis is a chronic disease associated with long periods of quiescent disease followed by fulminant exacerbation. Imminent relapse in UC is associated with high mucosal expression of SOCS3 and hence knowledge of the mechanisms driving mucosal SOCS3 expression may provide important clues as to rational therapy. Thus here we aimed to characterize the molecular forces driving SOCS3 expression in the mucosal compartment, focussing on drugable pathways. The colon epithelial cell line caco-2 was stimulated with IFN-γ, IL-4 or PGE(2) to allow correlations between SOCS3 expression with STAT1, STAT6 and cAMP signaling respectively. The physiological relevance of the findings obtained was assessed by immunohistochemical staining for the activated forms of STAT1, STAT6, PKA-Cγ and CREB in biopsies from inactive UC patients and controls. Stimulation with IFN-γ, IL-4 or PGE2 induced activation of respectively STAT1, STAT6 and cAMP in colonic cells, without any signs of concomitant STAT3 activation. Forced activation of all these signaling pathways was sufficient for SOCS3 expression. Biopsies from patients with inactive UC showed significant increase of p-STAT1 (p<0.0001), p-STAT6 (p=0.0001), p-PKA-Cγ (p=0.0003) and p-CREB (p=0.0025) expression as compared to controls. STAT3-independent SOCS3 induction in inactive UC involves multiple pro-inflammatory signaling pathways and argues against the usefulness of pathway-specific anti-inflammatory drugs for preventing relapse. Our findings suggest that broad-spectrum anti-inflammatory drugs are essential to counteract increases in SOCS3 expression and exacerbation of disease. Our results highlight the multi-factorial nature of the factors that cause exacerbation in UC.
    Molecular Medicine 11/2012; DOI:10.2119/molmed.2012.00277 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A natural carotenoid crocin is contained in saffron and gardenia flowers (crocuses and gardenias) and is used as a food colorant. This study reports the potential inhibitory effects of crocin against inflammation-associated mouse colon carcinogenesis and chemically induced colitis in male ICR mice. In the first experiment, dietary crocin significantly inhibited the development of colonic adenocarcinomas induced by azoxymethane (AOM) and dextran sodium sulfate (DSS) in mice by week 18. Crocin feeding also suppressed the proliferation and immunohistochemical expression of nuclear factor- (NF-) κB but increased the NF-E2-related factor 2 (Nrf2) expression, in adenocarcinoma cells. In the second experiment, dietary feeding with crocin for 4 weeks was able to inhibit DSS-induced colitis and decrease the mRNA expression of tumor necrosis factor α, interleukin- (IL-) 1β, IL-6, interferon γ, NF-κB, cyclooxygenase-2, and inducible nitric oxide synthase in the colorectal mucosa and increased the Nrf2 mRNA expression. Our results suggest that dietary crocin suppresses chemically induced colitis and colitis-related colon carcinogenesis in mice, at least partly by inhibiting inflammation and the mRNA expression of certain proinflammatory cytokines and inducible inflammatory enzymes. Therefore, crocin is a candidate for the prevention of colitis and inflammation-associated colon carcinogenesis.
    Evidence-based Complementary and Alternative Medicine 12/2012; 2012:820415. DOI:10.1155/2012/820415 · 1.88 Impact Factor

Similar Publications